DRAM1: A Potential Drug Target for Neurological Disorders (G55332)

Target Name: DRAM1

NCBI ID: G55332

DRAM1

DRAM1: A Potential Drug Target for Neurological Disorders

DRAM1, a DynamicRegulatory Adaptive Memory (DRAM) gene, has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. DRAM1 is a highly expressed gene in the brain and is involved in the regulation of memory and cognitive processes.

DRAM1 is a member of the DRAM gene family, which is known for its role in the regulation of memory and cognitive processes. The DRAM1 gene has four exons, which encode a protein that is expressed in the brain and is involved in the regulation of memory and cognitive processes.

Studies have shown that DRAM1 is involved in the regulation of various cognitive processes, including attention, memory, and spatial recognition.DRAM1 has also been shown to be involved in the regulation of emotional behavior and in the development of anxiety and depression.

In addition to its role in the regulation of cognitive processes, DRAM1 has also been shown to play a role in the regulation of cellular processes, including cell survival and proliferation. This suggests that DRAM1 may be involved in the development and progression of various neurological and psychiatric disorders.

As a potential drug target, DRAM1 is being studied for its potential therapeutic effects in a variety of disorders, including Alzheimer's disease, Parkinson's disease, and depression. Studies have shown that DRAM1 may be a promising target for these disorders because it is involved in the regulation of various cognitive and cellular processes that are disrupted in these disorders.

In addition to its potential therapeutic effects, DRAM1 is also being studied as a biomarker for various neurological and psychiatric disorders. This is because it is highly expressed in the brain and is involved in the regulation of various cognitive processes that are affected in these disorders.

DRAM1 may be a promising drug target and biomarker for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role in these disorders and to develop safe and effective treatments.

Protein Name: DNA Damage Regulated Autophagy Modulator 1

Functions: Lysosomal modulator of autophagy that plays a central role in p53/TP53-mediated apoptosis. Not involved in p73/TP73-mediated autophagy

The "DRAM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DRAM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets